Tiny noses, big clues: study hopes nose bugs predict preterm lung disease
NCT ID NCT07411261
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 270 preterm babies (born before 32 weeks) from birth to age 3. Researchers will regularly swab their noses to analyze the bacteria and other microbes living there. The goal is to see if the nose microbiome can predict which babies will develop bronchopulmonary dysplasia (a chronic lung disease) or later asthma and infections. This is an observational study, meaning no new treatment is being tested.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a way to predict which preterm babies are at risk for lung problems, allowing for earlier monitoring or treatment.
What could go wrong
This is an observational study, not a treatment trial. It may not find a clear link between the microbiome and lung disease, or the results may not apply to all preterm infants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA CHILDHOOD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service de néonatalogie, CH Cherbourg-en-Cotentin
Cherbourg, 50000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Service de néonatalogie, CHRU de Lille
Lille, 59000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Service de néonatalogie, CHU d'Amiens
Amiens, 80000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Service de néonatalogie, CHU de Caen
Caen, 14000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Service de néonatalogie, CHU de Rouen
Rouen, 76000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Service de néonatalogie, GHT du Havre
Le Havre, 76600, France
Contact Phone: •••-•••-•••• Email: •••••@•••••